Anti-CO4A2/ COL4A2/ ICH functional antibody

Anti-CO4A2/ COL4A2/ ICH functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to COL4A2/COL4A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0107-Ab-1/ GM-Tg-hg-SE0107-Ab-2Anti-Human COL4A2 monoclonal antibodyHuman
GM-Tg-rg-SE0107-Ab-1/ GM-Tg-rg-SE0107-Ab-2Anti-Rat COL4A2 monoclonal antibodyRat
GM-Tg-mg-SE0107-Ab-1/ GM-Tg-mg-SE0107-Ab-2Anti-Mouse COL4A2 monoclonal antibodyMouse
GM-Tg-cynog-SE0107-Ab-1/ GM-Tg-cynog-SE0107-Ab-2Anti-Cynomolgus/ Rhesus macaque COL4A2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0107-Ab-1/ GM-Tg-felg-SE0107-Ab-2Anti-Feline COL4A2 monoclonal antibodyFeline
GM-Tg-cang-SE0107-Ab-1/ GM-Tg-cang-SE0107-Ab-2Anti-Canine COL4A2 monoclonal antibodyCanine
GM-Tg-bovg-SE0107-Ab-1/ GM-Tg-bovg-SE0107-Ab-2Anti-Bovine COL4A2 monoclonal antibodyBovine
GM-Tg-equg-SE0107-Ab-1/ GM-Tg-equg-SE0107-Ab-2Anti-Equine COL4A2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0107-Ab-1/ GM-Tg-hg-SE0107-Ab-2; GM-Tg-rg-SE0107-Ab-1/ GM-Tg-rg-SE0107-Ab-2;
GM-Tg-mg-SE0107-Ab-1/ GM-Tg-mg-SE0107-Ab-2; GM-Tg-cynog-SE0107-Ab-1/ GM-Tg-cynog-SE0107-Ab-2;
GM-Tg-felg-SE0107-Ab-1/ GM-Tg-felg-SE0107-Ab-2; GM-Tg-cang-SE0107-Ab-1/ GM-Tg-cang-SE0107-Ab-2;
GM-Tg-bovg-SE0107-Ab-1/ GM-Tg-bovg-SE0107-Ab-2; GM-Tg-equg-SE0107-Ab-1/ GM-Tg-equg-SE0107-Ab-2
Products NameAnti-COL4A2 monoclonal antibody
Formatmab
Target NameCOL4A2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-COL4A2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0107-Ag-1Recombinant multi-species CO4A2/ COL4A2/ ICH protein


    Target information

    Target IDGM-SE0107
    Target NameCOL4A2
    Gene ID1284,12827,306628,100429807,403843,101096282,508632,100066264
    Gene Symbol and SynonymsBSVD2,Col4a-2,COL4A2,ICH,POREN2
    Uniprot AccessionP08572,Q7SIB3
    Uniprot Entry NameCO4A2_HUMAN,CO4A2_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseBreast Cancer, Prostate Cancer, Acute pancreatitis
    Gene EnsemblENSG00000134871
    Target ClassificationN/A

    The target: COL4A2, gene name: COL4A2, also named as ICH, POREN2. This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.